Getting Gene Therapies to Patients
This blog discusses the challenges that drug developers face in getting patients access to cell…
Certara2021年2月16日
Why Consistency in Patient Safety Narratives is Crucial
“You would not be able to tell 40 different writers were authoring these. It looked…
Certara2021年2月9日
8 Tips for Successfully Developing Oligonucleotide Therapies
By Eva Gil Berglund and Nathalie H Gosselin Oligonucleotide therapeutics are a validated class of…
Certara2021年2月1日
Dose Optimization using the Gene Therapy Virtual Twin Platform
This blog explains how using the Gene Therapy Virtual Twin™ Platform can help optimize dosing…
Certara2021年1月22日
Be Honest, Be Reliable, Be Human: Insights from a Global Drug Development Expert
One of the most exciting things about working in the pharmaceutical industry is the ability…
Certara2020年12月16日
Regulatory submissions and transactions with Health Canada
By Robert Labriola We’ve seen recent trends and activity with regards to pharmaceutical regulatory submissions…
Certara2020年11月19日
Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China
By Yuancheng Chen, Research Associate of Phase 1 Unit, Huashan Hospital, Fudan University, and visiting…
Certara2020年8月7日
The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development
3 key tips to set your pediatric program up for success with the RACE for…
Certara2020年7月14日
Local Therapies for the Global COVID-19 Pandemic
Henri Merdjan explains why topical drug formulations (e.g. intranasal and/or oral) could be valuable as…
Certara2020年5月29日
Applying decision analysis to drug development for COVID-19 & future pandemics
This blog discusses how decision analysis approaches can help drug developers to better decisions under…
Certara2020年4月30日
